Similar complication rates for irreversible electroporation and thermal ablation in patients with hepatocellular tumors

1Kokudo N, Hasegawa K, Akahane M, Igaki H, Izumi N, Ichida T, et al. Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res 2015; 45. doi: 10.1111/hepr.12464. Kokudo N Hasegawa K Akahane M Igaki H Izumi N Ichida T Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines) Hepatol Res 2015 45 10.1111/hepr.12464Open DOISearch in Google Scholar

2Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 2007; 6: 37-48. doi: 10.1177/153303460700600106 Rubinsky B Onik G Mikus P Irreversible electroporation: a new ablation modality—clinical implications Technol Cancer Res Treat 2007 6 3748 10.1177/153303460700600106Open DOISearch in Google Scholar

3Djokic M, Cemazar M, Popovic P, Kos B, Dezman R, Bosnjak M, et al. Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study. EJSO 2018; 44: 651-7. doi: 10.1016/j. ejso.2018.01.090 Djokic M Cemazar M Popovic P Kos B Dezman R Bosnjak M Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study EJSO 2018 44 6517 10.1016/j ejso.2018.01.090Open DOISearch in Google Scholar

4Davalos RV, Mir L, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33: 223. doi: 10.1007/s10439-005-8981-8 Davalos RV Mir L Rubinsky B Tissue ablation with irreversible electroporation Ann Biomed Eng 2005 33 223 10.1007/s10439-005-8981-8Open DOISearch in Google Scholar

5Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 1998; 227: 559-65. PMID: 9563546 Patterson EJ Scudamore CH Owen DA Nagy AG Buczkowski AK Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size Ann Surg 1998 227 55965 PMID: 9563546Search in Google Scholar

6Rossi S, Garbagnati F, De Francesco I, Accocella F, Leonardi L, Quaretti P, et al. Relationship between the shape and size of radiofrequency induced thermal lesions and hepatic vascularization. Tumori 1999; 85: 128-32. PMID: 10363079 Rossi S Garbagnati F De Francesco I Accocella F Leonardi L Quaretti P Relationship between the shape and size of radiofrequency induced thermal lesions and hepatic vascularization Tumori 1999 85 12832 PMID: 10363079Search in Google Scholar

7Goldberg SN, Hahn PF, Tanabe KK, Mueller PR, Schima W, Athanasoulis CA, et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998; 9(1 Pt 1): 101-11. PMID: 9468403 Goldberg SN Hahn PF Tanabe KK Mueller PR Schima W Athanasoulis CA Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998 91 Pt 1 10111 PMID: 9468403Search in Google Scholar

8Goldberg SN, Hahn PF, Halpern EF, Fogle RM, Gazelle GS. Radio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter. Radiology 1998; 209: 761-7. doi: 10.1148/radiol-ogy.209.3.9844671 Goldberg SN Hahn PF Halpern EF Fogle RM Gazelle GS Radio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter Radiology 1998 209 7617 10.1148/radiol-ogy.209.3.9844671Open DOISearch in Google Scholar

9Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect. AJR Am J Roentgenol 2002; 178: 47-51. doi: 10.2214/ajr.178.1.1780047 Lu DS Raman SS Vodopich DJ Wang M Sayre J Lassman C Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect AJR Am J Roentgenol 2002 178 4751 10.2214/ajr.178.1.1780047Open DOISearch in Google Scholar

10Dollinger M, Beyer LP, Haimerl M, Niessen C, Jung E-M, Zeman F, et al. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience. Diagn Interv Radiol 2015; 21: 471-5. doi: 10.5152/dir.2015.14442 Dollinger M Beyer LP Haimerl M Niessen C Jung E-M Zeman F Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience Diagn Interv Radiol 2015 21 4715 10.5152/dir.2015.14442Open DOISearch in Google Scholar

11Frühling P, Nilsson A, Duraj F, Haglund U, Norén A. Single-center non-randomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: short to mid-term results. EJSO 2017; 43: 751-7. doi: 10.1016/j.ejso.2016.12.004 Frühling P Nilsson A Duraj F Haglund U Norén A. Single-center non-randomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: short to mid-term results EJSO 2017 43 7517 10.1016/j.ejso.2016.12.004Open DOISearch in Google Scholar

12Distelmaier M, Barabasch A, Heil P, Kraemer NA, Isfort P, Keil S, et al. Midterm safety and efficacy of irreversible electroporation of malignant liver tumors located close to major portal or hepatic veins. Radiology 2017; 285: 1023-31. doi: 10.1148/radiol.2017161561 Distelmaier M Barabasch A Heil P Kraemer NA Isfort P Keil S Midterm safety and efficacy of irreversible electroporation of malignant liver tumors located close to major portal or hepatic veins Radiology 2017 285 102331 10.1148/radiol.2017161561Open DOISearch in Google Scholar

13Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients. Radiology 2009; 251: 933-40. doi: 10.1148/radiol.2513081740 Liang P Wang Y Yu X Dong B Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients Radiology 2009 251 93340 10.1148/radiol.2513081740Open DOISearch in Google Scholar

14Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol 2011; 21: 2584-96. doi: 10.1007/s00330-011-2222-3 Bertot LC Sato M Tateishi R Yoshida H Koike K Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review Eur Radiol 2011 21 258496 10.1007/s00330-011-2222-3Open DOISearch in Google Scholar

15Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 2012; 23: 727-36. doi: 10.1016/j.jvir.2012.02.012 Patel IJ Davidson JC Nikolic B Salazar GM Schwartzberg MS Walker TG Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions J Vasc Interv Radiol 2012 23 72736 10.1016/j.jvir.2012.02.012Open DOISearch in Google Scholar

16Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-13. doi: 10.1097/01. sla.0000133083.54934.ae Dindo D Demartines N Clavien PA Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 2004 240 20513 10.1097/01 sla.0000133083.54934.aeOpen DOISearch in Google Scholar

17Sahay A, Sahay N, Kapoor A, Kapoor J, Chatterjee A. Percutaneous image-guided radiofrequency ablation of tumors in inoperable patients - immediate complications and overall safety. Indian J Palliat Care 2016; 22: 67-73. doi: 10.4103/0973-1075.173951 Sahay A Sahay N Kapoor A Kapoor J Chatterjee A Percutaneous image-guided radiofrequency ablation of tumors in inoperable patients - immediate complications and overall safety Indian J Palliat Care 2016 22 6773 10.4103/0973-1075.173951Open DOISearch in Google Scholar

18Carrafiello G, Lagana D, Ianniello A, Dionigi G, Novario R, Recaldini C, et al. Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works. Australas Radiol 2007; 51: 550-4. doi: 10.1111/j.1440-1673.2007.01871.x Carrafiello G Lagana D Ianniello A Dionigi G Novario R Recaldini C Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works Australas Radiol 2007 51 5504 10.1111/j.1440-1673.2007.01871.xOpen DOISearch in Google Scholar

19Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD, Dupuy DE, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009; 20(7 Suppl): S377-90. doi: 10.1016/j.jvir.2009.04.011 Goldberg SN Grassi CJ Cardella JF Charboneau JW Dodd GD Dupuy DE Image-guided tumor ablation: standardization of terminology and reporting criteria J Vasc Interv Radiol 2009 207 Suppl S37790 10.1016/j.jvir.2009.04.011Open DOISearch in Google Scholar

20Feher J, Lengyel G. [Hepatocellular carcinoma: occurrence, risk factors, biomarkers]. Orv Hetil 2010; 151: 933-40. doi: 10.1556/oh.2010.28900 Feher J Lengyel G [Hepatocellular carcinoma: occurrence, risk factors, biomarkers] Orv Hetil 2010 151 93340 10.1556/oh.2010.28900Open DOISearch in Google Scholar

21Statistisches-Bundesamt. Diagnosedaten der krankenhäuser ab 2000 zweigstelle bonn june 2017 [updated 12. 06. 2017]. Available from: http://www.gbe-bund.de Statistisches-Bundesamt. Diagnosedaten der krankenhäuser ab 2000 zweigstelle bonn june 2017 [updated 12. 06. 2017] Available from http://www.gbe-bund.deSearch in Google Scholar

22Vauthey JN, Dixon E, Abdalla EK, Helton WS, Pawlik TM, Taouli B, et al. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB 2010; 12: 289-99. doi: 10.1111/j.1477-2574.2010.00181.x. Vauthey JN Dixon E Abdalla EK Helton WS Pawlik TM Taouli B Pretreatment assessment of hepatocellular carcinoma: expert consensus statement HPB 2010 12 28999 10.1111/j.1477-2574.2010.00181.xOpen DOISearch in Google Scholar

23Desjardins LA. Hepatocellular carcinoma. Clin J Oncol Nurs 2002; 6: 107-8. doi: 10.1188/02.cjon.107-108 Desjardins LA Hepatocellular carcinoma Clin J Oncol Nurs 2002 6 1078 10.1188/02.cjon.107-108Open DOISearch in Google Scholar

24Malek NP, Schmidt S, Huber P, Manns MP, Greten TF. The diagnosis and treatment of hepatocellular carcinoma. Dtsch Arztebl Int 2014; 111: 101-6. doi: 10.3238/arztebl.2014.0101. Malek NP Schmidt S Huber P Manns MP Greten TF The diagnosis and treatment of hepatocellular carcinoma Dtsch Arztebl Int 2014 111 1016 10.3238/arztebl.2014.0101Open DOISearch in Google Scholar

25EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 2018; 69: 182-236. doi: 10.1016/j.jhep.2018.03.019 EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma J Hepatol 2018 69 182236 10.1016/j.jhep.2018.03.019Open DOISearch in Google Scholar

26Raza A, Sood GK. Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World J Gastroenterol 2014; 20: 4115-27. doi: 10.3748/wjg.v20.i15.4115 Raza A Sood GK Hepatocellular carcinoma review: current treatment, and evidence-based medicine World J Gastroenterol 2014 20 411527 10.3748/wjg.v20.i15.4115Open DOISearch in Google Scholar

27Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36. doi: 10.1002/hep.24199 Bruix J Sherman M Management of hepatocellular carcinoma Hepatology 2005 42 120836 10.1002/hep.24199Open DOISearch in Google Scholar

28Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003; 52 (Suppl 3): iii1-8. doi: 10.1016/j. jvir.2013.09.005 Ryder SD Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults Gut 2003 52 Suppl 3 iii1-8 10.1016/j jvir.2013.09.005Open DOISearch in Google Scholar

29Ikai I, Kudo M, Arii S, Omata M, Kojiro M, Sakamoto M, et al. Report of the 18th follow-up survey of primary liver cancer in Japan. Hepatol Res 2010; 40: 1043-59. doi: 10.1111/j.1872-034X.2010.00731.x Ikai I Kudo M Arii S Omata M Kojiro M Sakamoto M Report of the 18th follow-up survey of primary liver cancer in Japan Hepatol Res 2010 40 104359 10.1111/j.1872-034X.2010.00731.xOpen DOISearch in Google Scholar

30Andreano A, Galimberti S, Franza E, Knavel EM, Sironi S, Lee FT, et al. Percutaneous microwave ablation of hepatic tumors: prospective evaluation of postablation syndrome and postprocedural pain. J Vasc Interv Radiol 2014; 25: 97-105. e2. doi: 10.1016/j.jvir.2013.09.005 Andreano A Galimberti S Franza E Knavel EM Sironi S Lee FT Percutaneous microwave ablation of hepatic tumors: prospective evaluation of postablation syndrome and postprocedural pain J Vasc Interv Radiol 2014 25 97105 e2 10.1016/j.jvir.2013.09.005Open DOISearch in Google Scholar

31Dodd GD, 3rd, Napier D, Schoolfield JD, Hubbard L. Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome. AJR Am J Roentgenol 2005; 185: 51-7. doi: 10.2214/ajr.185.1.01850051 Dodd GD 3rd Napier D Schoolfield JD Hubbard L Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome AJR Am J Roentgenol 2005 185 517 10.2214/ajr.185.1.01850051Open DOISearch in Google Scholar

32Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226: 441-51. doi: 10.1148/radiol.2262012198 Livraghi T Solbiati L Meloni MF Gazelle GS Halpern EF Goldberg SN Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study Radiology 2003 226 44151 10.1148/radiol.2262012198Open DOISearch in Google Scholar

33Fruhling P, Nilsson A, Duraj F, Haglund U, Noren A. Single-center non-randomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results. Eur J Surg Oncol 2017; 43: 751-7. doi: 10.1016/j.ejso.2016.12.004 Fruhling P Nilsson A Duraj F Haglund U Noren A Single-center non-randomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results Eur J Surg Oncol 2017 43 7517 10.1016/j.ejso.2016.12.004Open DOISearch in Google Scholar

34Zeng J, Liu G, Li ZH, Yang Y, Fang G, Li RR, et al. The safety and efficacy of irreversible electroporation for large hepatocellular carcinoma. Technol Cancer Res Treat 2017; 16: 120-4. doi: 10.1177/1533034616676445 Zeng J Liu G Li ZH Yang Y Fang G Li RR The safety and efficacy of irreversible electroporation for large hepatocellular carcinoma Technol Cancer Res Treat 2017 16 1204 10.1177/1533034616676445Open DOISearch in Google Scholar

35Omary RA, Bettmann MA, Cardella JF, Bakal CW, Schwartzberg MS, Sacks D, et al. Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol 2003; 14(9 Pt 2): S293-5. PMID: 12354820 Omary RA Bettmann MA Cardella JF Bakal CW Schwartzberg MS Sacks D Quality improvement guidelines for the reporting and archiving of interventional radiology procedures J Vasc Interv Radiol 2003 149 Pt 2 S2935 PMID: 12354820Search in Google Scholar